Viral Vaccines Media Market Segmented By Product Type such as Serum Media and Serum-Free Media with Application such as Buffer Preparation & Storage, Cell Culture, Cell Separation & Harvest, Chromatography, Media preparation, Volume Reduction – Ultrafiltration & Diafiltration
Industry: Healthcare
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Report Type: Ongoing
Report ID: PMRREP29941
Viral vaccines media offered a maximum infection rate and cell growth. In a suitable host cell, recombinant protein expression responsible for the production of viral vaccines. Moreover, susceptible to an animal infected with viral infections also produce viral vaccines. Different type of cell lines are used for the production of the viral vaccines, and most of the cells are developed from kidneys.
The viral vaccines media market is driven by the increasing need for safety for biological produced vaccination and therapy. Additionally, increasing production of biopharmaceuticals vaccination due to the rising use of biologics for the treatment of different viral disease contributing to the growth of the viral vaccines media market.
Increasing prevalence of viral infections such as viral hepatitis, HIV/AIDS, smallpox, and Ebola, etc. are the main key factors to increase the clinical research activities, hence, increasing the demand and market growth of viral vaccines media.
Over the past few decades, viral vaccines media have been very popular in the vaccine industry. HIV is one of the major public health issues, globally. In 2017, an estimated of 36.9 Mn people were living with HIV out of which 1.8 Mn is found to be children. The global HIV prevalence is around 0.8% among adults. Out of which 25% of people are unaware that they have HIV.
The majority of the HIV population living in low- and middle- income regions. In sub-Saharan Africa, around 66% of the population are living with HIV. In East and Southern Africa, 19.6 Mn population are living with HIV.
In 2017, around 800,000 new HIV infections detected. Especially young women are at risk of HIV with around 7 thousand new infections registered each week among young women aged 15-24 years.
In sub-Saharan Africa, 3 in 4 new infections are among aged 15–24 years and are twice more likely to be living with HIV than men population. The rising incidence of HIV and Hepatitis will increase the research and development activities and clinical researches for development of vaccines to control the burden of the disease, which likely to boost the growth of viral vaccines media market around the world.
| Product Type |
|
| Application |
|
| End Users |
|
| Region |
|
To know more about delivery timeline for this report Contact Sales
